Skip to main content
Moberg Pharma logo

Moberg Pharma — Investor Relations & Filings

Ticker · MOB ISIN · SE0020353928 LEI · 549300XFXK7DVGDRP410 ST Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2024-05-08 Major Shareholding Noti…
Country SE Sweden
Listing ST MOB

About Moberg Pharma

https://www.mobergpharma.com/

Moberg Pharma is a pharmaceutical company that develops and commercializes proprietary medical products, focusing on innovative drug delivery of proven compounds. The company's primary asset is MOB-015, a topical formulation for the treatment of onychomycosis (nail fungus). MOB-015 has demonstrated high fungal cure rates in Phase 3 clinical trials and has received market approval in multiple European countries. It is commercialized under the brand name Terclara® in Sweden and Norway, where it has achieved market leadership. Moberg Pharma's business model aims for lower development risk and faster market entry than traditional pharmaceutical development. The company's strategic goal is to establish MOB-015 as the leading global treatment for nail fungus.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for Moberg Pharma AB (publ) by Avanza Bank Holding AB. It explicitly mentions 'Reason for major shareholding notification' and provides the 'Before the transaction' and 'After the transaction' share counts and resulting percentages (4.8284% and 5.17798%). This structure is characteristic of a notification regarding a change in significant ownership, which aligns with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be a formal regulatory disclosure of this specific event.
2024-05-08 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport januari – mars 2024' (Interim Report January – March 2024) for Moberg Pharma AB. It contains comprehensive financial data, including income statements (Nettoomsättning, EBITDA, EBIT, Resultat efter skatt), balance sheet items (Likvida medel), and detailed management commentary on business performance, market launches, and clinical trial progress. It is a formal quarterly financial report, not an announcement of a report or a simple press release. Q1 2024
2024-05-07 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January – March 2024' for Moberg Pharma AB. It contains detailed financial highlights (Net revenue, EBITDA, EBIT, etc.), a CEO statement, and operational updates for the first quarter. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2024
2024-05-07 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically reporting that Avanza Bank Holding AB's pension entity now holds 1,441,298 shares, representing 5.07366% of the total. The structure includes fields like 'Reason for major shareholding notification Buy', 'Before the transaction', and 'After the transaction', along with specific share quantities and percentages. This content directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The appropriate code is MRQ.
2024-04-17 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details a change in shareholding, noting the 'Holder', the 'Issuer', the 'Reason for major shareholding notification' (Sell), the date (15/04/2024), and the resulting percentage (4.94765%) and number of shares (1,405,501). This structure perfectly matches the definition of a Major Shareholding Notification. The corresponding code is MRQ.
2024-04-16 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically noting the 'Reason for major shareholding notification Buy' and providing the 'Percentage' and 'Number of underlying shares' held by a specific entity (Avanza Bank Holding AB for Avanza Pension). This structure, focusing on ownership thresholds and changes, directly aligns with the definition of a Major Shareholding Notification. The filing type code MRQ (Major Shareholding Notification) is the most appropriate classification.
2024-04-15 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.